Literature DB >> 16327251

How healthy is the acutely reperfused ischemic penumbra?

J-C Baron1.   

Abstract

Because it is the main determinant of clinical recovery, early reperfusion of the ischemic penumbra has become the mainstay of acute stroke therapy. Although early permanent recanalization can be associated with spectacular and complete recovery, some patients in fact exhibit delayed or incomplete recovery, even despite small infarcts on late structural imaging. This might result from tissue inflammation and selective neuronal death/damage, two probably inter-related cellular events well described in the animal literature, precluding full functional restoration in the salvaged penumbra. However, impact of these processes on recovery may be complex because of the interplay with ongoing plasticity and the possible promoting effect of inflammation on the latter. Preliminary results from imaging studies of inflammation and selective neuronal loss after middle cerebral artery territory stroke, using radioligands of the central benzodiazepine receptor and the activated microglia, respectively, reviewed here, suggest these phenomena also exist in man, although their relationship with acute-stage hypoperfusion and their impact on clinical recovery, if any, remain poorly understood. Furthermore, their inter-relationships in the salvaged penumbra have not been addressed. Better understanding of these potentially harmful processes might help to maximize benefits from thrombolysis, and could also have implications for patients who enjoy spontaneous recanalization. 2005 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2005        PMID: 16327251     DOI: 10.1159/000089354

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  13 in total

1.  'Salvaged' stroke ischaemic penumbra shows significant injury: studies with the hypoxia tracer FMISO.

Authors:  Neil J Spratt; Geoffrey A Donnan; Damian D McLeod; David W Howells
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-29       Impact factor: 6.200

Review 2.  Imaging the physiological evolution of the ischemic penumbra in acute ischemic stroke.

Authors:  Richard Leigh; Linda Knutsson; Jinyuan Zhou; Peter Cm van Zijl
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-27       Impact factor: 6.200

3.  Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.

Authors:  Edward Tobinick
Journal:  CNS Drugs       Date:  2011-02       Impact factor: 5.749

4.  Neurogenic neuroprotection: clinical perspectives.

Authors:  Mauricio Mandel; Erich Talamoni Fonoff; Edson Bor-Seng-Shu; Manoel Jacobsen Teixeira; Gerson Chadi
Journal:  Funct Neurol       Date:  2012 Oct-Dec

Review 5.  Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery.

Authors:  R R Moustafa; J-C Baron
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

6.  Optimal Tmax threshold for predicting penumbral tissue in acute stroke.

Authors:  Jean-Marc Olivot; Michael Mlynash; Vincent N Thijs; Stephanie Kemp; Maarten G Lansberg; Lawrence Wechsler; Roland Bammer; Michael P Marks; Gregory W Albers
Journal:  Stroke       Date:  2008-12-24       Impact factor: 7.914

7.  Regional distribution of selective neuronal loss and microglial activation across the MCA territory after transient focal ischemia: quantitative versus semiquantitative systematic immunohistochemical assessment.

Authors:  Julius V Emmrich; Sohail Ejaz; Jonas J Neher; David J Williamson; Jean-Claude Baron
Journal:  J Cereb Blood Flow Metab       Date:  2014-10-29       Impact factor: 6.200

Review 8.  Clinical review: Imaging in ischaemic stroke--implications for acute management.

Authors:  Ramez Reda Moustafa; Jean-Claude Baron
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

9.  A program for solving the brain ischemia problem.

Authors:  Donald J DeGracia
Journal:  Brain Sci       Date:  2013-04-08

Review 10.  Selective neuronal loss in ischemic stroke and cerebrovascular disease.

Authors:  Jean-Claude Baron; Hiroshi Yamauchi; Masayuki Fujioka; Matthias Endres
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-06       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.